Journal
KIDNEY INTERNATIONAL SUPPLEMENTS
Volume 4, Issue 1, Pages 53-57Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/kisup.2014.10
Keywords
DDR1; periostin; renal inflammation and fibrosis
Categories
Funding
- INSERM
- UPMC
- AstraZeneca
- Agence Nationale de Recherche (ANR)
- CoPoc INSERM
- Major State Basic Research Development Program of China [2012CB517700]
- Guangdong Medical Association
Ask authors/readers for more resources
Over the last decade, identification and characterization of novel markers of progression and targets for therapy of chronic kidney disease (CKD) have been challenging for the research community. Several promising candidates have emerged, mainly from experimental models of CKD that are yet to be investigated in clinical studies. The authors identified two candidate genes: periostin, an extracellular matrix protein involved in bone and dental development, and the discoidin domain receptor 1 (DDR1), a collagen-binding membrane receptor with tyrosine kinase activity. Both genes are inactive in adulthood under normal conditions but have been shown to be highly inducible following injury to glomerular or tubular epithelial cells. The objective of this review is to summarize recent evidence supporting the role of periostin and DDR1 as potential novel biomarkers and therapeutic targets in CKD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available